TAE Life Sciences’ Research on Boronotyrosine (BTS) Drug Shows Promise in Advancing Cancer-Fighting Potential of BNCT

Journal of Medicinal Chemistry Publishes Study Demonstrating BTS’s Advantages in Cancer Care IRVINE, Calif., Nov. 21, 2023 /PRNewswire/ — TAE Life Sciences, a pioneer in advancing Boron Neutron Capture Therapy (BNCT) for cancer treatment, today announced groundbreaking findings from its…

Click here to view original post